SCHEMBL10489503

SCHEMBL10489503

CC[C@@H](C)C(C)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL822429 1.00
SCHEMBL93407 1.00
SCHEMBL425852 1.00
SCHEMBL30033233 1.00
SCHEMBL842357 0.97
SCHEMBL8723287 0.97
SCHEMBL18259771 0.84 ALDH1A1 (0.41)
Tetrahydrofuran SCHEMBL8912584 0.81 ALDH1A1 (0.40)
SCHEMBL3668894 0.77 ALDH1A1 (0.32)
SCHEMBL17953985 0.77 PTPN1 (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4320254-A1 SUSTAINABLE PROCESS FOR THE PREPARATION OF 5-METHYLHEPT-2-EN-4-ONE Symrise AG (DE) 2024-02-14 EP disclosed
US-20230321048-A1 ANTIBODY DRUG CONJUGATES COMPRISING STING AGONISTS MERSANA THERAPEUTICS, INC. 2023-10-12 US disclosed
US-20230172910-A1 ANTIBODY DRUG CONJUGATES COMPRISING STING AGONISTS MERSANA THERAPEUTICS, INC. 2023-06-08 US disclosed
WO-2022214180-A1 SUSTAINABLE PROCESS FOR THE PREPARATION OF 5-METHYLHEPT-2-EN-4-ONE SYMRISE AG (DE) 2022-10-13 WO disclosed
WO-2017172763-A1 SYNTHESIS AND APPLICATION OF CHIRAL SUBSTITUTED POLYVINYLPYRROLIDINONES KANSAS STATE UNIVERSITY RESEARCH FOUNDATION (US) 2017-10-05 WO disclosed
US-9738685-B2 Use of ruthenium complexes for preparing amides, polypeptides and cyclic dipeptides YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2017-08-22 US disclosed
US-20170107251-A1 NOVEL RUTHENIUM COMPLEXES AND THEIR USES IN PROCESSES FOR FORMATION AND/OR HYDROGENATION OF ESTERS, AMIDES AND DERIVATIVES THEREOF YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2017-04-20 US disclosed
US-9487570-B2 Glucagon like peptide analogs, composition, and method of use BETTA PHARMACEUTICALS CO., LTD (CN) 2016-11-08 US disclosed
US-20160152663-A1 USE OF RUTHENIUM COMPLEXES FOR FORMATION AND/OR HYDROGENATION OF AMIDES AND RELATED CARBOXYLIC ACID DERIVATIVES YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2016-06-02 US disclosed
EP-2817322-B1 HOMO- AND HETERODIMERIC SMAC MIMETIC COMPOUNDS AS APOPTOSIS INDUCERS UNIV DEGLI STUDI MILANO (IT) 2016-04-20 EP disclosed
US-8809371-B2 2014-08-19 US disclosed
US-20130281664-A1 NOVEL RUTHENIUM COMPLEXES AND THEIR USES IN PROCESSES FOR FORMATION AND/OR HYDROGENATION OF ESTERS, AMIDES AND DERIVATIVES THEREOF YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2013-10-24 US disclosed
US-20130261057-A1 METHODS FOR THERAPEUTIC TREATMENT OF BENIGN PROSTATIC HYPERTROPHY (BPH) KLEINBERG DAVID L (US) 2013-10-03 US disclosed
US-20130116430-A1 NOVEL NICOTINAMIDE DERIVATIVE OR SALT THEREOF FUJIFILM CORPORATION (JP) 2013-05-09 US disclosed
US-8288142-B2 Hyaluronidase and method of use thereof UVARKINA TAMARA P (RU) 2012-10-16 US disclosed
US-20120253042-A1 USE OF RUTHENIUM COMPLEXES FOR FORMATION AND/OR HYDROGENATION OF AMIDES AND RELATED CARBOXYLIC ACID DERIVATIVES YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2012-10-04 US disclosed
EP-1735307-B1 INHIBITORS OF IAP NOVARTIS AG (CH) 2012-08-29 EP disclosed
US-20100172892-A1 HYALURONIDASE AND METHOD OF USE THEREOF UVARKINA TAMARA P 2010-07-08 US disclosed
WO-2008011074-A2 HISTONE DEACETYLASE INHIBITORS ERRANT GENE THERAPEUTICS, LLC (US) 2008-01-24 WO disclosed
US-4795821-A Optically active borinic esters and ketones ALDRICH-BORANES, INC. (US) 1989-01-03 US disclosed